Permanent leadless cardiac pacing: Results of the LEADLESS trial

Vivek Y. Reddy, Reinoud E. Knops, Johannes Sperzel, Marc A. Miller, Jan Petru, Jaroslav Simon, Lucie Sediva, Joris R. De Groot, Fleur V.Y. Tjong, Peter Jacobson, Alan Ostrosff, Srinivas R. Dukkipati, Jacob S. Koruth, Arthur A.M. Wilde, Josef Kautzner, Petr Neuzil

Research output: Contribution to journalArticlepeer-review

244 Scopus citations

Abstract

Background-: Conventional cardiac pacemakers are associated with several potential short-and long-term complications related to either the transvenous lead or subcutaneous pulse generator. We tested the safety and clinical performance of a novel, completely self-contained leadless cardiac pacemaker. Methods and Results-: The primary safety end point was freedom from complications at 90 days. Secondary performance end points included implant success rate, implant time, and measures of device performance (pacing/sensing thresholds and rate-responsive performance). The mean age of the patient cohort (n=33) was 77±8 years, and 67% of the patients were male (n=22/33). The most common indication for cardiac pacing was permanent atrial fibrillation with atrioventricular block (n=22, 67%). The implant success rate was 97% (n=32). Five patients (15%) required the use of >1 leadless cardiac pacemaker during the procedure. One patient developed right ventricular perforation and cardiac tamponade during the implant procedure, and eventually died as the result of a stroke. The overall complication-free rate was 94% (31/33). After 3 months of follow-up, the measures of pacing performance (sensing, impedance, and pacing threshold) either improved or were stable within the accepted range. Conclusions-: In a prospective nonrandomized study, a completely self-contained, single-chamber leadless cardiac pacemaker has shown to be safe and feasible. The absence of a transvenous lead and subcutaneous pulse generator could represent a paradigm shift in cardiac pacing. Clinical Trial Registration-: URL: http://clinicaltrials.gov. Unique identifier: NCT01700244.

Original languageEnglish
Pages (from-to)1466-1471
Number of pages6
JournalCirculation
Volume129
Issue number14
DOIs
StatePublished - 8 Apr 2014

Keywords

  • pacemaker, cardiac

Fingerprint

Dive into the research topics of 'Permanent leadless cardiac pacing: Results of the LEADLESS trial'. Together they form a unique fingerprint.

Cite this